protein

Influenza A, H1N1 New Caledonia 20/99, Hemagglutinin, Recombinant

MBS636376

0.002 mg

345 USD

Recombinant Protein

Influenza A, H1N1 New Caledonia 20/99, Hemagglutinin, Recombinant

[Influenza A, H1N1 New Caledonia 20/99, Hemagglutinin]

Baculovirus Insect cells

Highly Purified. >90% by SDS-PAGE. Analysis by SDS-PAGE under reducing conditions resulted in the detection of HA1 and HA2 bands.

Supplied as a sterile solution in 10mM sodium phosphate, pH 7.2, 150mM sodium chloride, 0.005% tween-20

0.82 mg/ml

May be stored at 4°C for short-term only. For long term storage aliquot and store at 4°C . Do not freeze. Aliquots are stable for 6 months after receipt. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer.

ELISA and Lateral Flow Assay. Other applications have not been tested

Optimal dilutions to be determined by the researcher

Molecular Biology; MB-Infectious Disease

H1N1 is a subtype species of Influenza A virus. H1N1 Influenza Virus has mutated into various strains such as Spanish Flustrain, mild humanflu strains, endemic pig stains, and various strains found in birds. The Influenza Virus is a globular particle about 100nm in diameter, sheathed in lipid bilayer are two integral membrane proteins some 500 molecules of hemagglutinin ("H") and some 100 molecules of neuraminidase ("N"). Within the lipid bilayer are 3000 molecules of matric protein and 8 pieces of RNA. Each of the 8 RNA molecules is associated with many copies of a nucleoprotein, several molecules of the three subunits of its RNA polymerase some "non-structural" protein molecules of uncertain function. Recombinant full-length H1N1 A/New Caledonia/20/99 (MW 72kD) is glycosylated with N-linked sugars and produced using baculovirus vectors in insect cells. The insect cells were infected with A9440.1a, recombinant baculovirus expressing recombinant H1N1 A/New Caledonia/20/99. H1N1 New Caledonia shows 90% similarity to the A/PR/8/34 amino acid sequence. (Accession #DQ508857)

~72kD

0.002 mg

345 USD

0.01 mg

490